Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Nudelman

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Investigational New Drugs|September 9, 2017
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repairLilach Moyal, Neta Goldfeiz, Batia Gorovitz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 11, 2016
Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent mannerAda Rephaeli, Nataly Tarasenko, Eitan Fibach, et al.
Oncology Research|September 8, 2007
Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistanceSuzanne M Cutts, Abraham Nudelman, Vinochani Pillay, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2012
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adductsRobert A Forrest, Lonnie P Swift, Benny J Evison, et al.
Blood|October 18, 2002
The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell linesAyse Batova, Li-en Shao, Mitchell B Diccianni, et al.
Journal of Medicinal Chemistry|March 28, 2008
A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effectsAbraham Nudelman, Irit Gil-Ad, Nava Shpaisman, et al.
Journal of Medicinal Chemistry|April 24, 2018
Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory AgentsShani Zeeli, Tehilla Weill, Efrat Finkin-Groner, et al.
Neuro-Oncology|March 10, 2007
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomasMichal Entin-Meer, Xiaodong Yang, Scott R VandenBerg, et al.
Biochemical Pharmacology|March 15, 2012
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formationRobert A Forrest, Lonnie P Swift, Ada Rephaeli, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 25, 2017
Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse ModelMichal Schaap-Fogler, Irit Bahar, Ada Rephaeli, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Investigational New Drugs|September 9, 2017
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repairLilach Moyal, Neta Goldfeiz, Batia Gorovitz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 11, 2016
Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent mannerAda Rephaeli, Nataly Tarasenko, Eitan Fibach, et al.
Oncology Research|September 8, 2007
Formaldehyde-releasing prodrugs in combination with adriamycin can overcome cellular drug resistanceSuzanne M Cutts, Abraham Nudelman, Vinochani Pillay, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2012
The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adductsRobert A Forrest, Lonnie P Swift, Benny J Evison, et al.
Blood|October 18, 2002
The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell linesAyse Batova, Li-en Shao, Mitchell B Diccianni, et al.
Journal of Medicinal Chemistry|March 28, 2008
A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effectsAbraham Nudelman, Irit Gil-Ad, Nava Shpaisman, et al.
Journal of Medicinal Chemistry|April 24, 2018
Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory AgentsShani Zeeli, Tehilla Weill, Efrat Finkin-Groner, et al.
Neuro-Oncology|March 10, 2007
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomasMichal Entin-Meer, Xiaodong Yang, Scott R VandenBerg, et al.
Biochemical Pharmacology|March 15, 2012
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formationRobert A Forrest, Lonnie P Swift, Ada Rephaeli, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 25, 2017
Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse ModelMichal Schaap-Fogler, Irit Bahar, Ada Rephaeli, et al.
Pageof 7